{"id":"https://openalex.org/W2153409705","doi":"https://doi.org/10.1177/026988119901300204","title":"Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines","display_name":"Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines","publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2153409705","doi":"https://doi.org/10.1177/026988119901300204","mag":"2153409705","pmid":"https://pubmed.ncbi.nlm.nih.gov/10475718"},"language":"en","primary_location":{"id":"doi:10.1177/026988119901300204","doi":"https://doi.org/10.1177/026988119901300204","is_oa":false,"landing_page_url":"https://doi.org/10.1177/026988119901300204","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059567824","display_name":"Rodney L. Dunn","orcid":"https://orcid.org/0000-0002-4148-8538","observed_orcids":["https://orcid.org/0000-0002-4148-8538"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodney L. Dunn","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111619244","display_name":"J. Donoghue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Donoghue","raw_affiliation_strings":["PCS Health, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PCS Health, Liverpool, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024321250","display_name":"Ronald J. Ozminkowski","orcid":"https://orcid.org/0000-0001-5555-4797","observed_orcids":["https://orcid.org/0000-0001-5555-4797"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald J. Ozminkowski","raw_affiliation_strings":["The MEDSTAT Group, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The MEDSTAT Group, Ann Arbor, MI, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083562801","display_name":"D. Stephenson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Deborah Stephenson","raw_affiliation_strings":["Lilly Industries, Basingstoke, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Industries, Basingstoke, UK","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050872889","display_name":"Timothy R. Hylan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy R. Hylan","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":5.5653,"has_fulltext":false,"cited_by_count":99,"citation_normalized_percentile":{"value":0.9654424,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"13","issue":"2","first_page":"136","last_page":"143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.1151999980211258,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10214","display_name":"Psychotherapy Techniques and Applications","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressant-prescribing","display_name":"antidepressant prescribing","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.8510000109672546},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":1.0},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.5989999771118164},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6510000228881836},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.6990000009536743},{"id":"https://openalex.org/keywords/amitriptyline","display_name":"amitriptyline","score":0.7509999871253967},{"id":"https://openalex.org/keywords/dothiepin","display_name":"dothiepin","score":0.8090000152587891},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lofepramine","display_name":"lofepramine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/guideline-concordant-prescribing","display_name":"guideline-concordant prescribing","score":0.5}],"concepts":[{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.765398383140564},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.748054563999176},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.7407496571540833},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7008075714111328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6600902080535889},{"id":"https://openalex.org/C2779657639","wikidata":"https://www.wikidata.org/wiki/Q908843","display_name":"Tricyclic antidepressant","level":4,"score":0.598751962184906},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5431926846504211},{"id":"https://openalex.org/C2780216858","wikidata":"https://www.wikidata.org/wiki/Q58397","display_name":"Amitriptyline","level":2,"score":0.5312228798866272},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5282306671142578},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5084130167961121},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.475435733795166},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4470785856246948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41344964504241943},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.15527525544166565},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/026988119901300204","doi":"https://doi.org/10.1177/026988119901300204","is_oa":false,"landing_page_url":"https://doi.org/10.1177/026988119901300204","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:10475718","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10475718","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"},{"id":"pmh:oai:deepblue.lib.umich.edu:2027.42/68732","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2027.42/68732>","pdf_url":null,"source":{"id":"https://openalex.org/S4306400393","display_name":"Deep Blue (University of Michigan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I27837315","host_organization_name":"University of Michigan","host_organization_lineage":["https://openalex.org/I27837315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W54798487","https://openalex.org/W135918856","https://openalex.org/W1970387771","https://openalex.org/W1974946748","https://openalex.org/W1996695042","https://openalex.org/W2011353529","https://openalex.org/W2031872745","https://openalex.org/W2033280909","https://openalex.org/W2037664045","https://openalex.org/W2037892857","https://openalex.org/W2044885685","https://openalex.org/W2052223361","https://openalex.org/W2067437035","https://openalex.org/W2067711950","https://openalex.org/W2070395519","https://openalex.org/W2083991574","https://openalex.org/W2090550959","https://openalex.org/W2106075952","https://openalex.org/W2131179717","https://openalex.org/W2162966898","https://openalex.org/W2164418318","https://openalex.org/W2292639945","https://openalex.org/W2731812427","https://openalex.org/W4248498496"],"related_works":["https://openalex.org/W2030269239","https://openalex.org/W4283737403","https://openalex.org/W2049987508","https://openalex.org/W1973040393","https://openalex.org/W2319158043","https://openalex.org/W2017025675","https://openalex.org/W2033585427","https://openalex.org/W2021487630","https://openalex.org/W2001162284","https://openalex.org/W2106075952"],"abstract_inverted_index":{"The":[0],"objective":[1],"of":[2,29,67,74,82,116,132,136,144,199,222,227,238],"this":[3],"study":[4],"was":[5,34,63,104,156],"to":[6,106,180],"determine":[7],"whether":[8,108,223],"patients":[9,69,137,145,166,204],"beginning":[10],"therapy":[11,76,79,118,139,147,169,201,207],"on":[12,80,140,148,170,208],"the":[13,41,57,60,83,126,195,224,236,241],"most":[14,84],"common":[15],"tricyclic":[16],"antidepressants":[17],"(TCAs)":[18],"and":[19,91,97,142,187],"selective":[20],"serotonin":[21],"reuptake":[22],"inhibitors":[23],"(SSRIs)":[24],"differed":[25],"in":[26,40,240],"their":[27],"likelihood":[28],"having":[30],"antidepressant":[31,75,117,153,216],"treatment":[32,38,154,159,192,228,237],"that":[33,155,214],"consistent":[35,157,189,230],"with":[36,70,158,190,231],"recommended":[37,191],"guidelines":[39,193,234],"UK.":[42,242],"An":[43],"analytical":[44],"file":[45],"constructed":[46],"from":[47,56],"a":[48,71,149,171,182,209],"large":[49],"general":[50],"practitioner":[51],"medical":[52],"records":[53],"database":[54],"(DIN-LINK)":[55],"UK":[58],"for":[59,163,235],"years":[61],"1992-97":[62],"constructed.":[64],"A":[65,101],"total":[66],"16,204":[68],"new":[72],"episode":[73],"who":[77,167,205],"initiated":[78,168,206],"one":[81],"often":[85],"prescribed":[86,111,152,183],"TCAs":[87],"(amitriptyline,":[88],"dothiepin,":[89],"imipramine":[90],"lofepramine)":[92],"or":[93],"SSRIs":[94],"(fluoxetine,":[95],"paroxetine":[96],"sertraline)":[98],"were":[99,110,151,173,203],"analysed.":[100],"dichotomous":[102],"measure":[103],"defined":[105],"indicate":[107],"subjects":[109],"at":[112,119],"least":[113],"120":[114],"days":[115],"an":[120,219],"adequate":[121],"average":[122,184],"daily":[123,185],"dose":[124,186],"within":[125,194],"first":[127,196],"6":[128,197],"months":[129,198],"after":[130],"initiation":[131],"therapy.":[133],"Only":[134],"6.0%":[135],"initiating":[138,146,200],"aTCA":[141],"32.9%":[143],"SSRI":[150,172],"guidelines.":[160],"After":[161],"controlling":[162],"observable":[164],"characteristics,":[165],"much":[174],"more":[175],"likely":[176],"(odds":[177],"ratio=7.473,":[178],"p<0.001)":[179],"have":[181],"duration":[188],"than":[202],"TCA.":[210],"These":[211],"findings":[212],"suggest":[213],"initial":[215],"selection":[217],"is":[218,229],"important":[220],"determinant":[221],"subsequent":[225],"course":[226],"current":[232],"national":[233],"depression":[239]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}